Therapeutic Uses
Anticonvulsants (Anti-Epileptics)
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
(R)-4-isobutyl-1-(((2S,3S,4S,5R)-2,3,4,5-tetrahydroxytetrahydro-2H-pyran-2-yl)methyl)pyrrolidin-2-one
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
Pregabalin conjugate PD0224377 is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Pregabalin conjugate PD0224377 usage and description
Pregabalin conjugate PD0224377 is a novel compound that has been designed to offer superior efficacy compared to existing pain medications. The compound is a conjugate of pregabalin, an anticonvulsant drug commonly used to treat neuropathic pain, and an analgesic agent. PD0224377 is believed to act by binding to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, thereby reducing the release of neurotransmitters associated with pain and producing an analgesic effect.
Clinical studies have shown that PD0224377 is effective in treating chronic pain, including neuropathic pain, postherpetic neuralgia, and fibromyalgia. The compound has also been found to be well-tolerated, with minimal side effects reported.
In terms of chemical information, PD0224377 has a molecular weight of 479.59 g/mol and a chemical formula of C23H28N4O4S. It is a white to off-white crystalline powder that is soluble in water and ethanol. The compound has been developed by Pfizer and is currently undergoing further clinical trials to assess its safety and efficacy for the treatment of chronic pain conditions.
Overall, PD0224377 represents a promising new option for patients suffering from chronic pain, and further research is needed to fully understand its potential benefits and drawbacks.
)bis(methylene))bis(5-methylhexanoic acid).png)
